Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report

Medicine
Yen-Tung ChaoLung Chan

Abstract

Whether intravenous recombinant tissue plasminogen activator (r-TPA) therapy can be administered in acute ischemic stroke patients treated with novel oral anticoagulants (NOACs), including rivaroxaban, remains controversial. A 76-year-old woman with nonvalvular atrial fibrillation, who had been receiving 15 mg rivaroxaban once daily, was brought to the emergency department with right-side hemiparesis and aphasia. The onset of neurological deficits occurred 8 hours after the last dose of rivaroxaban administration. The patient was diagnosed with acute ischemic stroke. Intravenous infusion of 0.6 mg/kg of r-TPA (total dose: 29 mg) was performed 9 hours and 40 minutes after the last rivaroxaban administration. During r-TPA infusion, improvement in the patient's neurological deficit was observed. The clinical picture evidently improved from with National Institutes of Health Stroke Scale 21 to 16 on completion of r-TPA treatment. Although current guidelines do not recommend administering thrombolytics in patients using NOACs with a doubtful anticoagulation status and administered within the last 24 or, even more strictly, 48 hours, this and other case studies suggest that r-TPA treatment could be considered in selected acute ischem...Continue Reading

References

Dec 14, 2011·Stroke; a Journal of Cerebral Circulation·Mark J AlbertsDavid A Garcia
Dec 22, 2011·Thrombosis and Haemostasis·Meyer Michel SamamaUNKNOWN Rivaroxaban Anti-Factor Xa Chromogenic Assay Field Trial Laboratories
Jun 1, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·András FolyovichDániel Bereczki
Jul 5, 2013·Thrombosis Journal·Meyer Michel SamamaJean-Luc Martinoli
Dec 19, 2013·Cerebrovascular Diseases Extra·Felix FluriChristoph Kleinschnitz
Jun 19, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Katharina Bornkamm, Andreas Harloff
Jul 6, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Andrew J NealStephen M Davis
Aug 19, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D J SeiffgeS T Engelter
Oct 5, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Hideyuki IshiharaMichiyasu Suzuki
Jan 7, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Anne Landais, Caroline Ginoux
Mar 27, 2015·Thrombosis and Haemostasis·M Cappellari, P Bovi
Apr 9, 2015·British Journal of Hospital Medicine·Justin PengeRobert Simister
Apr 23, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Chise AnanKentaro Yamada
Jul 27, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Lucia NardettoBruno Giometto
Sep 2, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hein HeidbuchelPaulus Kirchhof

❮ Previous
Next ❯

Citations

Oct 5, 2021·Frontiers in Pharmacology·Sandra ThalerováRobert Mikulík

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Hideyuki IshiharaMichiyasu Suzuki
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Satoshi KimuraYoshio Tsuboi
© 2022 Meta ULC. All rights reserved